Platte River Capital’s Bristol-Myers Squibb BMY Stock Holding History

Platte River Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$308K	Sell	5,210 -25,510	-83%	-$1.62M	0.28%	91
2015 Q2	$2.04M	Sell	30,720 -4,000	-12%	-$264K	1.03%	33
2015 Q1	$2.24M	Sell	34,720 -6,700	-16%	-$419K	1.01%	36
2014 Q4	$2.44M	Sell	41,420 -28,035	-40%	-$1.58M	0.91%	36
2014 Q3	$3.56M	Sell	69,455 -67,290	-49%	-$3.36M	0.92%	37
2014 Q2	$6.63M	Sell	136,745 -59,330	-30%	-$2.92M	1.01%	27
2014 Q1	$10.2M	Sell	196,075 -51,350	-21%	-$2.73M	1.38%	10
2013 Q4	$13.2M	Sell	247,425 -22,830	-8%	-$1.16M	1.69%	6
2013 Q3	$12.5M	Sell	270,255 -20,830	-7%	-$914K	1.54%	12
2013 Q2	$13M	Buy	+291,085	New	+$12.6M	1.51%	12

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Platte River Capital's BMY Position: Q3 2015 in Review

Platte River Capital reduced its Bristol-Myers Squibb (BMY) stake by 83% in Q3 2015, selling an estimated $1.62M and leaving 5,210 shares worth $308K. The position accounts for 0.28% of the portfolio, ranked #91.

Platte River Capital first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $13.2M in Q4 2013. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

Platte River Capital held 5,210 shares of Bristol-Myers Squibb worth $308K as of Q3 2015.
Platte River Capital sold 25,510 Bristol-Myers Squibb shares in Q3 2015, an estimated $1.62M.
Bristol-Myers Squibb made up 0.28% of Platte River Capital's portfolio in Q3 2015, its #91 holding.
Platte River Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
Platte River Capital's Bristol-Myers Squibb position peaked at $13.2M in Q4 2013.
1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.